Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Betrixaban (Portola) is one example that I know of that missed the primary endpoint in cohort 1 (narrowly). The subsequent analyses were considered exploratory and were significant. The drug still was approved on the basis of this trial.
